SAN ANTONIO--(BUSINESS WIRE)--Vidacare Corporation announced today that the Centers for Medicare & Medicaid Services (CMS) has created a new device category for pass-through payment for Powered Bone Marrow Biopsies. Providers utilizing new powered bone marrow devices such as Vidacare’s OnControlTM Bone Marrow System (OnControl System) in outpatient hospital and ambulatory surgical centers will now be reimbursed by CMS to accommodate the use of more sophisticated technology, giving clinicians the ability to choose the best biopsy option for patients.
